Status
Conditions
About
The goal of this study is to evaluate the overall impact of Telehomecare on COPD and HF patients and system level outcomes using a comparison group of patients that did not participate in the program (for up to 18 months). This evaluation study will explore costs, participants' experiences, perceptions, and patterns of use related to Telehomecare. The study will include eight Local Health Integration Networks (LHINs) across Ontario, Canada.
Full description
The key question to answer is how different models of Telehomecare enabled self-management impacts patient outcomes, experiences and system costs across Ontario. The evaluation study will also attempt to answer questions on who is benefitting the most from the program and the quantifiable benefits a patient would experience from participating.
The intervention evaluation study will use a mixed-methods design comprising of four components (sub-studies), using both qualitative and quantitative research methods: (1) Comparative Effectiveness Study that evaluates patient-level clinical outcomes (e.g. hospitalization, ED visits) using administrative data in comparison with usual care; (2) Economic Evaluation Study that will evaluate costs associated with the program and patient level outcomes as well as cost-effectiveness of the program in comparison with 'usual care'; (3) Evaluation study of Telehomecare use that will evaluate the patterns of program use and perceived quality of life, disease management, satisfaction and caregiver strain; and (4) Adoption study that will use ethnographic fieldwork, semi-structured interviews (during and after program participation) and review of documentary sources to gain understanding of program adoption.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patient:
The patient has a documented diagnosis of HF or COPD (with or without co-morbid conditions);
The patient has been classified as a 'heavy user' of the health care system, characterized by any of the following:
Patient/informal caregiver (if applicable) is an adult (over 18 years), able and willing to provide informed consent;
Patient/informal caregiver (if applicable) is fluent in English;
Patient/informal caregiver is able and willing to operate the Telehomecare equipment; and
Patient lives in a residential (private home or retirement home) setting with an active landline.
In addition to the program eligibility criteria, the following criteria for the intervention evaluation study apply to recruitment of patients:
Healthcare Provider
A healthcare provider that has:
Technicians, Administrators, and/or Decision Makers
The following are eligible for inclusion in the study:
Exclusion criteria
Patient
Less than 18 years of age;
Individuals without an established diagnosis of COPD or HF
Unable or unwilling to provide verbal informed consent
Demonstrated non-adherence to the THC program:
o The Telehomecare Nurse works with each patient on a case-by-case review to assess willingness to partner in their own care, and if the number of missed consultation appointments and reasons for demonstrate overall non-adherence with the program;
Inability or unwillingness to use Telehomecare equipment, and/or;
Do not have a regular caregiver to assist in the use of the equipment (if assistance is required)
Healthcare Provider
Technicians, Administrators and/or Decision Makers
5,400 participants in 7 patient groups
Loading...
Central trial contact
Valeria Rac, MD, PhD; Nida Shahid
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal